Loading
Latest filing published 18 Mar 2025 for Kalaris Therapeutics, Inc..
No signal scores available.
Only one filing by Napoleone Ferrara is known so far (18 March 2025): a share grant, in Kalaris Therapeutics, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration